Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy.
Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has been reported, but the underlying mechanism remains elusive.38 CHB patients treated with ADV for one year were selected for studying genotype shift by both deep sequencing and Sanger sequencing method.Sanger sequ...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4482366?pdf=render |
| _version_ | 1819239970903162880 |
|---|---|
| author | Yuwei Wang Xuefeng Shan Zhi Liang Youlan Shan Wenxiang Huang Dazhi Zhang Aizhong Zen Xin Zhou Yao Zhao Xuyang Gong Ge Xu Xiuyu Zhang Juan Chen Ailong Huang |
| author_facet | Yuwei Wang Xuefeng Shan Zhi Liang Youlan Shan Wenxiang Huang Dazhi Zhang Aizhong Zen Xin Zhou Yao Zhao Xuyang Gong Ge Xu Xiuyu Zhang Juan Chen Ailong Huang |
| author_sort | Yuwei Wang |
| collection | DOAJ |
| description | Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has been reported, but the underlying mechanism remains elusive.38 CHB patients treated with ADV for one year were selected for studying genotype shift by both deep sequencing and Sanger sequencing method.Sanger sequencing method found that 7.9% patients showed mixed genotype before ADV therapy. In contrast, all 38 patients showed mixed genotype before ADV treatment by deep sequencing. 95.5% mixed genotype rate was also obtained from additional 200 treatment-naïve CHB patients. Of the 13 patients with genotype shift, the fraction of the minor genotype in 5 patients (38%) increased gradually during the course of ADV treatment. Furthermore, responses to ADV and HBeAg seroconversion were associated with the high rate of genotype shift, suggesting drug and immune pressure may be key factors to induce genotype shift. Interestingly, patients with genotype C had a significantly higher rate of genotype shift than genotype B. In genotype shift group, ADV treatment induced a marked enhancement of genotype B ratio accompanied by a reduction of genotype C ratio, suggesting genotype C may be more sensitive to ADV than genotype B. Moreover, patients with dominant genotype C may have a better therapeutic effect. Finally, genotype shifts was correlated with clinical improvement in terms of ALT.Our findings provided a rational explanation for genotype shift among ADV-treated CHB patients. The genotype and genotype shift might be associated with antiviral efficiency. |
| first_indexed | 2024-12-23T14:00:35Z |
| format | Article |
| id | doaj.art-204cfb116588469b8793fc60e5d5d692 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-23T14:00:35Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-204cfb116588469b8793fc60e5d5d6922022-12-21T17:44:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01106e013133710.1371/journal.pone.0131337Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy.Yuwei WangXuefeng ShanZhi LiangYoulan ShanWenxiang HuangDazhi ZhangAizhong ZenXin ZhouYao ZhaoXuyang GongGe XuXiuyu ZhangJuan ChenAilong HuangViral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has been reported, but the underlying mechanism remains elusive.38 CHB patients treated with ADV for one year were selected for studying genotype shift by both deep sequencing and Sanger sequencing method.Sanger sequencing method found that 7.9% patients showed mixed genotype before ADV therapy. In contrast, all 38 patients showed mixed genotype before ADV treatment by deep sequencing. 95.5% mixed genotype rate was also obtained from additional 200 treatment-naïve CHB patients. Of the 13 patients with genotype shift, the fraction of the minor genotype in 5 patients (38%) increased gradually during the course of ADV treatment. Furthermore, responses to ADV and HBeAg seroconversion were associated with the high rate of genotype shift, suggesting drug and immune pressure may be key factors to induce genotype shift. Interestingly, patients with genotype C had a significantly higher rate of genotype shift than genotype B. In genotype shift group, ADV treatment induced a marked enhancement of genotype B ratio accompanied by a reduction of genotype C ratio, suggesting genotype C may be more sensitive to ADV than genotype B. Moreover, patients with dominant genotype C may have a better therapeutic effect. Finally, genotype shifts was correlated with clinical improvement in terms of ALT.Our findings provided a rational explanation for genotype shift among ADV-treated CHB patients. The genotype and genotype shift might be associated with antiviral efficiency.http://europepmc.org/articles/PMC4482366?pdf=render |
| spellingShingle | Yuwei Wang Xuefeng Shan Zhi Liang Youlan Shan Wenxiang Huang Dazhi Zhang Aizhong Zen Xin Zhou Yao Zhao Xuyang Gong Ge Xu Xiuyu Zhang Juan Chen Ailong Huang Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy. PLoS ONE |
| title | Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy. |
| title_full | Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy. |
| title_fullStr | Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy. |
| title_full_unstemmed | Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy. |
| title_short | Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy. |
| title_sort | deep sequencing analysis of hbv genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy |
| url | http://europepmc.org/articles/PMC4482366?pdf=render |
| work_keys_str_mv | AT yuweiwang deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT xuefengshan deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT zhiliang deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT youlanshan deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT wenxianghuang deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT dazhizhang deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT aizhongzen deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT xinzhou deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT yaozhao deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT xuyanggong deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT gexu deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT xiuyuzhang deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT juanchen deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy AT ailonghuang deepsequencinganalysisofhbvgenotypeshiftandcorrelationwithantiviralefficiencyduringadefovirdipivoxiltherapy |